Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Conjugated oestrogens + Bazedoxifene
Duavive
Not routinely available
SMC (1220/17)
16/01/2017
Indication
Treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus (with at least 12 months since the last menses) for whom treatment with progestin-containing therapy is not appropriate.
Therapeutic Area
Obstetrics, gynaecology, and urinary-tract disorders
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
0.45mg/20mg modified-release tablets
Comments
None
Link to Advice
Advice Published
16/01/2017
SMC Submission Type
Non submission
SMC Status
Not recommended